Home / Inspections / 1097760

FDA Inspection 1097760 — Carter BloodCare - Longview

Carter BloodCare - Longview — FEI 1626972

The FDA completed an inspection of Carter BloodCare - Longview on June 5, 2019 in Longview, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 5, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Longview, TX (United States)

Facility

Other inspections at this facility

  • 1262070 (NAI Thu Feb 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1017197 (NAI Fri Jun 23 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 932717 (NAI Wed Jun 17 2015 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 821700 (NAI Tue Mar 05 2013 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 730855 (NAI Tue Jun 21 2011 00:00:00 GMT+0000 (Coordinated Universal Time))

FDA data resources